Offers Invited
Hilco is delighted to offer for sale the shares or business and assets of Project AI-Write, an innovative business specialising in AI-powered medical writing solutions (the “Company”).
The Company has developed a state-of-the-art AI platform specifically designed to streamline the complex and costly production of Clinical Study Reports, critical documents in the pharmaceutical regulatory approval process. Utilising advanced proprietary technology, the Company’s solution significantly reduces manual labour, operational costs, and time while maintaining exceptional accuracy and consistency.
Furthermore, the Company’s platform is fully accredited, boasting ISO, SOC, and HIPAA certifications, demonstrating its commitment to security and quality standards in healthcare technology. Having successfully onboarded initial clients and secured £1.26m in funding, acquiring the business/shares of the Company represents a prime opportunity for strategic investors looking to capitalise on the rapidly growing, lucrative niche market of medical writing.
Upon signing a confidentiality agreement, prospective purchasers will be granted access to a secure virtual data room for further detailed information.
Should you require further information on the opportunity please contact Yasmin Saadi (ysaadi@hilcoglobaladvisors.co.uk) and Alexander Muir (amuir@hilcoglobaladvisors.co.uk).
No warranties, express or implied, are provided in relation to any information or statements made in connection to this opportunity. The information contained herein, and within the project dataroom, has not been verified by Hilco and prospective purchasers must undertake their own due diligence to satisfy themselves as to the accuracy of all such information and any statements made. Hilco’s full Terms and Conditions apply. Hilco acts as agent for the Vendor who offers for sale only such right, title and interest the Company possesses in the assets.
Associate Director
Manchester Office
